WLTH carries a consistent story into its September 9 earnings event: a stock trading below where analysts set their price targets, with the Street repeatedly marking those targets lower.
The analyst direction is the defining feature of this setup. Every major revision since June has been a cut. Goldman Sachs lowered its target to $10.50, Wells Fargo trimmed to $11.50 most recently in early August, and JPMorgan and KBW have both reduced their numbers across multiple rounds. All four firms kept their ratings intact — Overweight or Market Perform — but the persistent target compression tells a clear story. The mean consensus target of roughly $16 was struck in January and is now materially stale; the more relevant anchors are the recent cuts, which cluster in the $10.50–$13 range. With the stock at $9.58, it trades at a modest discount to even the most cautious of those revised estimates, which gives bulls a valuation argument while bears note that the Street has been consistently wrong-footed on the upside.
The lending market offers no particular drama ahead of the print. Borrow availability is generous at around 540% — meaning roughly five and a half shares are available for every one currently shorted — and has actually loosened considerably over the past six weeks. Short interest has fallen 16% over the past month to roughly 6 million shares, and borrowing costs are negligible at 0.55%. The ORTEX short score of 49 sits squarely in neutral territory. Options positioning is equally subdued: the put/call ratio of 0.88 is almost exactly in line with its 20-day average, with a z-score near zero. Neither bears nor options traders are making aggressive pre-earnings statements.
Ownership is dominated by long-term venture and growth investors, with founder Andrew Rachleff holding nearly 12% and Tiger Global, DAG Ventures, and Index Ventures each above 6%. One notable shift: Meyer Malka filed a 13G/A in August reducing his stake from 6.7% to 4.2%, slipping below the 5% disclosure threshold. All 13D/G stakes are as last disclosed and holders dropping below 5% may not file again. The recent insider activity has been entirely planned sales under 10b5-1 programs — the CTO, a director, and the VP of Engineering each sold small tranches — none of which carry conviction signals. The stock has given back about 2.5% over the past month despite a 3.6% bounce this week to close at $9.58.
The print will test whether Wealthfront's digital-native growth model is generating enough revenue momentum to justify a re-rating closer to analyst targets, or whether ongoing fee pressure and competitive intensity from larger platforms continue to compress the valuation ceiling the Street keeps being forced to lower.
See the live data behind this article on ORTEX.
Open WLTH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
